Thursday, May 19, 2022
wellness India Expo
Home Tags IQVIA

Tag: IQVIA

“India continues to remain a key destination for clinical trials”

Jinu Jose, Vice President, Head – Sales and Clinical Operations, R&D Solutions, IQVIA India shared his views on the company's current operations, market scenario and future outlook

Global medicine spending to reach $1.8 trillion in 2026: IQVIA study

A total of 300 new drugs are expected to be launched over the next five years to 2026, significantly higher than levels seen on average during the past decade, and are expected to skew toward specialty, niche and orphan drugs

“IQVIA offers a custom-built delivery model for biotech industry”

This edition of Chat with BioVoice features Suneela Thatte, Vice President & Head, R & D Solutions, IQVIA India who believes that the demand for faster and better drug development brought on by the pandemic is only going to accelerate the adoption of digital technologies........................

Managing Covid-19 3rd wave: NATHEALTH submits recommendations to govt

The submission also included findings from a recent patient study conducted by NATHEALTH with IQVIA in 2021 on the impact of COVID-19 and delay in treatment, on patient behavior due to restrictions in accessing healthcare facilities......................

IQVIA Biotech launches in Asia Pacific & Japan, dedicated to emerging...

Since its launch, IQVIA Biotech has initiated hundreds of new trials for biotech companies, including COVID-19 trial.......................

IQVIA & Medvarsity collaborate to provide flexible medical training solutions for...

Collaboration expands access to specialized courses for HCPs. Through this strategic alliance, professionals on HCP Space will be able to access more than 150 courses in clinical and management areas................

IQVIA & AstraZeneca team-up to support development of potential COVID-19 vaccine

Operation Warp Speed is part of a broader strategy to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.......................

COVID-19 V: Q2 Solutions partners University of Texas to accelerate vaccine...

IQVIA and Quest Diagnostics joint venture has announced its collaboration with the University of Texas Medical Branch (UTMB) to develop a novel assay for COVID-19 (SARS-CoV-2) tests, an essential tool for rapid development of a Coronavirus vaccine...............

IQVIA named to FORTUNE Mag’s 2020 list of world’s most admired...

IQVIA has got recognized in FORTUNE’s Healthcare: Pharmacy and Other Services category with high marks regarding efficient use of corporate assets, management quality, effectiveness in conducting business globally, and long-term investment value.................

IQVIA lights buildings purple for World Alzheimer’s Day

According to Alzheimer’s Disease International, the number of people living with dementia around the world is over 50 million, which is expected to almost double every 20 years, reaching 152 million by 2050.................